Clinical Trial Update: Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CANn cannabidiol's effects on anxiety and GABAergic function in individuals with Fragile X syndrome, currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• CANn cannabidiol (cannabidiol)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Fragile X Syndrome | Phase 2 | Status: NOT_YET_RECRUITING